11
podcast episode
Ep. 49: Time Equals Lives, with FasterCures’ Esther Krofah
“We spend numerous hours a day updating that tracker because what is critical is real-time informa
tion that researchers and scientists can respond to....As I've been speaking to colleagues, ranging from NIH to these large companies, they're usin
+ Read More
landing page
Achieving Health Equity and Diversity in Clinical Trials
The underrepresentation of diverse groups in clinical research, mistrust in research, and the lack o
f diversity in the health workforce play significant roles in the persistence of health inequities.
+ Read More
landing page
Changemakers
What is the power of philanthropy to disrupt the biomedical innovation ecosystem?, Members are Guide
d by the Following Statement of Purpose
We are a collective of philanthropic innovators that have come together to:, FasterCures’ Changemakers Members
Jeff Allen, CEO, Friends of Cancer Research
Margaret Anderson, Managing Director, Deloitte (FasterCures Board Liaison)
+ Read More
report
The Current Landscape of the Science of Patient Input
In the last decade, FasterCures and many stakeholders across the biomedical research ecosystem have
driven initiatives to ensure that patients’ perspectives and input are appropriately represented across the product-development continuum and post-approv
+ Read More
panel
UAE Medical Research and Health System Site Visit (Invite only)
A small delegation of leading health experts from the FasterCures board and MENA Summit will tou
r institutions in Abu Dhabi to expand participants' understanding of UAE investments in health and biomedical research.
+ Read More
podcast episode
Ep. 50: Special Edition — Potential Breakthroughs in COVID-19 Research Coming From Cancer Research
For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther
Krofah (Executive Director, FasterCures) join Mike for a special discussion on how breakthroughs in cancer laboratories are advancing our understa
+ Read More
video
How COVID-19 Tests Will Help Reopen America - Conference Call Series
There is widespread recognition that our ability to efficiently perform testing for COVID-19 on a
large scale—whether to diagnose current cases or determine who might have immunity—is key to restarting economic activity in the US.
+ Read More
video
Ep. 50: Special Edition - Potential Breakthroughs in COVID-19 Research Coming From Cancer Research
For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther
Krofah (Executive Director, FasterCures) join Mike for a special discussion on how breakthroughs in cancer laboratories are advancing our understanding an
+ Read More
video
Research Roadmaps: A Case Study in Charting a Path Forward to Accelerate Breakthrough Cures
Setting specific objectives and establishing strategies geared toward progressing treatments and c
ures is a critical, yet sometimes difficult, task for patient organizations.
+ Read More
article
Milken Institute COVID-19 tracker update identifies more than 100 vaccines and nearly 200 treatments in development
Nine vaccines and more than 50 treatment candidates currently in clinical trials.
article
How COVID-19 Tests Will Help Reopen America
.bubble-images, .bubble-images img {
border-radius: 50%;
}
How COVID-19 Tests Will Help Reopen Ame
rica
Tuesday, May 19 | 8 am PT
+ Read More